Document Detail


Evaluating and managing patients with thyrotoxicosis.
MedLine Citation:
PMID:  23145395     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background Thyrotoxicosis is common in the Australian community and is frequently encountered in general practice. Graves disease, toxic multinodular goitre, toxic adenoma and thyroiditis account for most presentations of thyrotoxicosis. Objective This article outlines the clinical presentation and evaluation of a patient with thyrotoxicosis. Management of Graves disease, the most frequent cause of thyrotoxicosis, is discussed in further detail. Discussion The classic clinical manifestations of thyrotoxicosis are often easily recognised by general practitioners. However, the presenting symptoms of thyrotoxicosis are varied, with atypical presentations common in the elderly. Following biochemical confirmation of thyrotoxicosis, a radionuclide thyroid scan is the most useful investigation in diagnosing the underlying cause. The selection of treatment differs according to the cause of thyrotoxicosis and the wishes of the individual patient. The preferred treatment for Graves disease is usually antithyroid drug therapy, almost always carbimazole. The primary treatment of a toxic multinodular goitre or toxic adenoma is usually radioactive iodine therapy. Specific therapy is usually not warranted in cases of thyroiditis, however, treatment directed at symptoms may be required. Referral to an endocrinologist is recommended if thyroiditis is unlikely or has been excluded.
Authors:
Kirsten Campbell; Matthew Doogue
Related Documents :
21076055 - Validation of the taiwan triage and acuity scale: a new computerised five-level triage ...
21263335 - Disparity in perceived illness intrusiveness and illness severity: between cardiac pati...
17119965 - Usefulness of the msg/ificg/eortc diagnostic criteria of invasive pulmonary aspergillos...
21554685 - Walk-ins seeking treatment at an emergency department or general practitioner out-of-ho...
556235 - Relevance of the barium follow-through examination in the diagnosis of adult celiac dis...
3669745 - Monocyte esterase? a factor involved in the pathogenesis of lymphoproliferative neoplasia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Australian family physician     Volume:  41     ISSN:  0300-8495     ISO Abbreviation:  Aust Fam Physician     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326701     Medline TA:  Aust Fam Physician     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  564-72     Citation Subset:  IM    
Affiliation:
MBBS, FRACP, is an endocrinologist, Department of Endocrinology, The Queen Elizabeth Hospital, Adelaide, South Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypothyroidism.
Next Document:  Goitre - Causes, investigation and management.